FIELD: medicine. SUBSTANCE: method involves exposing target cell of complex in biological fluid containing complement to membrane attack applied to complement and identifying lysis. The target cells are treated with complement in presence of polymer initiator of alternative path. Analysis takes 10-15 min. EFFECT: enhanced accuracy of analysis. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINING INDICATIONS FOR TREATMENT BY CYTOSTATICS AND GLUCO-CORTICOSTEROIDS | 1996 |
|
RU2112986C1 |
| METHOD FOR DETERMINATION OF COMPLEMENT ACTIVITY | 0 |
|
SU1727075A1 |
| MONOCLONAL ANTIBODY SS3-4 TO CONFORMATION HUMAN EPITOPE C3, STRAIN OF HYBRID MOUSE DNA RKKK(P)764D - PRODUCER OF MONOCLONAL ANTIBODY SS3-4 | 2015 |
|
RU2584582C1 |
| METHOD FOR DETERMINING INTEGRAL FUNCTIONAL ACTIVITY OF COMPLEMENT MEMBRANE ATTACK COMPLEX COMPONENTS | 2013 |
|
RU2542397C1 |
| METHOD OF DETERMINING HEMOLYTIC ACTIVITY OF PROTEOLYTIC COMPONENTS OF ALTERNATIVE ROUTE OF COMPLEMENT | 0 |
|
SU1532876A1 |
| METHOD OF DETERMINING THROMBIN COMPLEMENTARITY SYSTEM ACTIVATION PATHWAY | 2019 |
|
RU2717946C1 |
| DETERMINING OF CIRCULATING THROMBIN IN COMPLEMENT ACTIVATION TEST | 2019 |
|
RU2709341C1 |
| METHOD FOR DETERMINING INTEGRAL FUNCTIONAL ACTIVITY OF HUMAN COMPLEMENT COMPONENT C1 | 2013 |
|
RU2542399C1 |
| METHOD FOR DETERMINING COMPLEMENT ACTIVITY DUE TO ALTERNATIVE WAY | 0 |
|
SU1798695A1 |
| METHOD FOR DETERMINATION OF PREPARATION INFLUENCE ON INTERACTION OF COMPLEMENT WITH ANTIGEN-ANTIBODY COMPLEX | 2017 |
|
RU2669342C1 |
